Bowman & Company’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
9,241
+15
| +0.2% | +$4.13K | 1.14% | 22 |
|
|
2025
Q1 | $2.45M | Buy |
9,226
+614
| +7% | +$163K | 1.2% | 21 |
|
|
2024
Q4 | $2M | Buy |
8,612
+188
| +2% | +$43.7K | 1.03% | 25 |
|
|
2024
Q3 | $1.86M | Buy |
8,424
+768
| +10% | +$169K | 0.97% | 26 |
|
|
2024
Q2 | $1.51M | Buy |
7,656
+621
| +9% | +$122K | 0.87% | 29 |
|
|
2024
Q1 | $1.52M | Sell |
7,035
-62
| -0.9% | -$13.4K | 0.91% | 25 |
|
|
2023
Q4 | $1.5M | Buy |
7,097
+408
| +6% | +$86K | 1.04% | 22 |
|
|
2023
Q3 | $1.34M | Buy |
6,689
+365
| +6% | +$73.1K | 1.07% | 24 |
|
|
2023
Q2 | $1.17M | Buy |
6,324
+256
| +4% | +$47.4K | 0.89% | 26 |
|
|
2023
Q1 | $1.16M | Buy |
6,068
+1,155
| +24% | +$221K | 0.85% | 27 |
|
|
2022
Q4 | $826K | Sell |
4,913
-59
| -1% | -$9.92K | 0.64% | 34 |
|
|
2022
Q3 | $881K | Buy |
4,972
+216
| +5% | +$38.3K | 0.8% | 26 |
|
|
2022
Q2 | $973K | Buy |
4,756
+773
| +19% | +$158K | 0.85% | 26 |
|
|
2022
Q1 | $947K | Buy |
3,983
+614
| +18% | +$146K | 0.73% | 23 |
|
|
2021
Q4 | $773K | Buy |
+3,369
| New | +$773K | 0.6% | 27 |
|